venBio Global Strategic Fund III L.P. 13D and 13G filings for Pharvaris N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-24 6:41 pm Purchase |
2023-12-06 | 13D | Pharvaris N.V. PHVS |
venBio Global Strategic Fund III L.P. | 4,382,504 8.400% |
117,832 (+2.76%) |
Filing |
| 2023-06-21 4:33 pm Purchase |
2023-06-16 | 13D | Pharvaris N.V. PHVS |
venBio Global Strategic Fund III L.P. | 4,264,672 10.400% |
1,963,221 (+85.30%) |
Filing |
| 2022-09-26 4:24 pm Sale |
2021-02-09 | 13D | Pharvaris N.V. PHVS |
venBio Global Strategic Fund III L.P. | 2,301,451 6.900% |
-1,859 (-0.08%) |
Filing |
| 2021-02-19 4:49 pm Purchase |
2021-02-09 | 13D | Pharvaris N.V. PHVS |
venBio Global Strategic Fund III L.P. | 2,303,310 7.000% |
2,303,310 (New Position) |
Filing |